Genetics of Obsessive-Compulsive Disorder
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00001548|
Recruitment Status : Completed
First Posted : November 4, 1999
Last Update Posted : October 6, 2017
The purpose of this study is to identify genes that affect susceptibility to obsessive-compulsive disorder (OCD). By identifying genes that increase or decrease the risk of OCD, researchers can better understand how the condition develops and ultimately improve treatment for people with OCD.
OCD is a severe, familial condition that affects approximately 2% of the population. The way OCD is inherited is not clearly understood, but researchers believe it is complex and involves multiple genes. This study will detect and localize genes that increase or decrease susceptibility to OCD. The data collected from this study will be combined with data from other research studies to determine gene linkage and association.
|Condition or disease|
|Obsessive Compulsive Disorder|
|Study Type :||Observational|
|Actual Enrollment :||1067 participants|
|Official Title:||Genetics of Obsessive-Compulsive Disorder: A Collaborative Study|
|Study Start Date :||August 22, 1996|
|Estimated Study Completion Date :||September 29, 2015|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001548
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Francis J McMahon, M.D.||National Institute of Mental Health (NIMH)|